3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
28
Phase 3
6
Phase 2/3
3
Phase NA
1
Phase 4
1
Phase 1/2
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
14
INDUSTRY
10
OTHER_GOV
1
NIH
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
3
Radiotherapy
3
Propranolol
3
Cisplatin
3
entecavir
2
Tranexamic Acid
2
Pemetrexed
2
Metformin
2
Erythromycin
2
Epinephrine
2
Cyclophosphamide
2
Chemoradiotherapy
2
Bortezomib
2
ulipristal acetate
1
tislelizumab
1
plerixafor
1
lobaplatin
1
ledipasvir
1
eribulin
1
endostar protein
1
dolutegravir
1
colistinmethanesulfonic acid
1
cetrorelix
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
XELOX
1
Vancomycin
1
Vacuum Curettage
1
Vaccination
1
Suction
1
Sofosbuvir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER_GOV
×
Capecitabine
×
Clear all
NCT07483060
2026-03-19
NG-ST
Vastra Gotaland Region
Phase 4
Not yet recruiting
90 enrolled